DOI: https://doi.org/10.14710/jai.v0i0.73897

Target-Controlled Infusion (TCI) Propofol in Ventriculoperitoneal (VP) Shunt Surgery during the First Trimester of Pregnancy

1Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Cendrawasih/RSUD Jayapura, Papua, Indonesia

2Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Padjadjaran/RSUP Dr. Hasan Sadikin, Bandung, Indonesia

Received: 30 May 2025; Revised: 6 Sep 2025; Accepted: 24 Oct 2025; Available online: 24 Oct 2025.
Open Access Copyright 2025 JAI (Jurnal Anestesiologi Indonesia)
Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.

Citation Format:
Cover Image
Abstract

Background: The use of target-controlled infusion (TCI) propofol in pregnant patients undergoing ventriculoperitoneal (VP) shunt surgery during the first trimester due to hydrocephalus presents a rare and complex challenge in neuroanesthesia. TCI propofol is favoured for its ability to maintain hemodynamic stability and effectively control intracranial pressure (ICP), both of which are crucial in neuro-obstetric management.

Case: A 23-year-old woman, five weeks pregnant, with a history of communicating hydrocephalus and bilateral VP shunts, presented with severe headache. She underwent emergency VP shunt revision under general anesthesia using TCI propofol (Schnider model, target effect-site concentration 2.5–5 mcg/mL), fentanyl (2 mcg/kg), atracurium (0.5 mg/kg), and lidocaine (1.5 mg/kg). Intraoperative hemodynamics remained stable throughout the two-hour procedure. Postoperatively, her neurological status improved significantly, and no complications were observed.

Discussion: Compared to inhalational agents such as sevoflurane, TCI propofol demonstrates superior control of ICP, maintains cerebral blood flow stability, and facilitates faster postoperative recovery. Fentanyl, atracurium, and lidocaine were selected due to their favourable safety profiles for short-term use in pregnancy. Postoperatively, progesterone was administered to support pregnancy maintenance by reducing uterine contractility and mitigating the risk of miscarriage associated with surgical and anesthetic stress.

Conclusion: TCI propofol is an effective and safe anesthetic strategy for managing VP shunt procedures during the first trimester of pregnancy. A multidisciplinary approach is essential to achieve optimal neurological and obstetric outcomes.

 

Note: This article has supplementary file(s).

Fulltext View|Download |  common.other
Copyright Transfer Agreement
Subject
Type Other
  Download (415KB)    Indexing metadata
Keywords: hydrocephalus; neuro-obstetrics; pregnancy; TCI propofol; VP shunt

Article Metrics:

Article Info
Section: Case Reports
Language : EN
Recent articles
COMPARISON OF THE EFFICACY OF INTRAVENOUS NOREPINEPHRINE AND PHENYLEPHRINE AS VASOPRESSOR AGENTS IN THE MANAGEMENT OF SEPTIC SHOCK IN ICU PATIENTS AT HAJI ADAM MALIK GENERAL HOSPITAL USING LACTATE AND STROKE VOLUME VARIATION INDICATORS ERECTOR SPINAE PLANE BLOCK IN THORACOTOMY SURGERY Target-Controlled Infusion (TCI) Propofol in Ventriculoperitoneal (VP) Shunt Surgery during the First Trimester of Pregnancy Intensive Care Management of a Patient With Pickwickian Syndrome, Obesity, and Congestive Heart Failure More recent articles
Most cited articles
Patofisiologi Penyakit Jantung Koroner Midazolam Intravena Dosis Rendah Tidak Mempengaruhi Nitric Oxide Intraperitoneal Mencit Balb/C Yang Terpapar Lipopolisakarida More cited articles
  1. Bidkar PU, Dey A, Chatterjee P, Ramadurai R, Joy JJ. Target-controlled infusion – past, present, and future. J Anaesthesiol Clin Pharmacol. 2024;40(3):371–80. doi: 10.4103/joacp.joacp_64_23
  2. Kannabiran N, Bidkar PU. Total intravenous anesthesia in neurosurgery. J Neuroanaesth Crit Care. 2018;5(3):141–9. doi: 10.1055/s-0038-1673544
  3. Dewan MC, Rattani A, Mekary R, et al. Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. J Neurosurg. 2018;130(4):1065–79. doi: 10.3171/2017.10.JNS17439
  4. Rahmayani DD, Gunawan PI, Utomo B. Profil klinis dan faktor risiko hidrosefalus komunikans dan non komunikans pada anak di RSUD dr. Soetomo. Sari Pediatri. 2017;19(1):25–31. doi: 10.14238/sp19.1.2017.25-31
  5. Singh S, Sethi N. Neuroanesthesia and pregnancy: uncharted waters. Med J Armed Forces India. 2019;75(2):125–9. doi: 10.1016/j.mjafi.2018.10.001
  6. Neumann L. Clinical application of target controlled infusion: a review. Clin Res Trials. 2019;5:2–5. doi: 10.15761/CRT.1000259
  7. Nguyen A, Smith J, Doe P, Brown L, Taylor K, Johnson R, et al. Neuroprotective effects of anesthetics in neurosurgery: a systematic review. Biomedicines. 2023;11(2):372. doi: 10.3390/biomedicines11020372
  8. Zhou Z, Wang Q, Zhao X, Liu W, Wang Y, Sun J, et al. Comparison of intravenous propofol versus inhalational sevoflurane for neurosurgical anesthesia: a meta-analysis. Medicine (Baltimore). 2021;100(51):e28400. doi: 10.1097/MD.0000000000028400
  9. Choudhary D, Gupta R, Kumar P, Sharma A. Propofol versus sevoflurane for anesthesia in neurosurgical patients: a comparative review. Surg Neurol Int. 2023;14:151. doi: 10.25259/SNI_1076_2022
  10. American College of Obstetricians and Gynecologists. ACOG Opinion No. 775: nonobstetric surgery during pregnancy. Obstet Gynecol. 2019;133:e285–6. doi: 10.1097/AOG.0000000000003174
  11. Li X, Zhang W, Cheng J, Huang L, Wu H, Li Z. Pharmacokinetic profile of propofol in pregnancy: implications for anesthesia. Front Pharmacol. 2021;11:523514. doi: 10.3389/fphar.2020.523514
  12. Okeagu CN, Huang J, Wang X, Guo Y, Liu Y. Neuroprotective effects of inhalational anesthetics in traumatic brain injury: a narrative review. Medicina. 2025;61(4):698. doi: 10.3390/medicina61040698
  13. Liang FW, Lin YH, Tsai CY, Chang WY, Kuo LC, Chen SC. Safety profile of anesthetic agents in pregnant women undergoing surgery: a population-based cohort study. BMC Pregnancy Childbirth. 2022;22(1):307. doi: 10.1186/s12884-022-04732-w
  14. MotherToBaby (OTIS). Fentanyl. Updated July 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK582701/
  15. Winters E. Pharmacology and clinical application of atracurium. OpenAn. 2023;7(1):e025. doi: 10.1097/OA9.000000000000025
  16. Lee JJ, Park HS, Han JI, Kim YH, Choi SJ. Intravenous lidocaine for hemodynamic stability during anesthesia induction: a randomized trial. Korean J Anesthesiol. 2020;73(3):215–24. doi: 10.4097/kja.19460
  17. Devroe S, Bleeser T, Van de Velde M, Verbrugge L, De Buck F. Anesthesia for non-obstetric surgery during pregnancy: clinical considerations. Curr Opin Anaesthesiol. 2019;32(3):255–61. doi: 10.1097/ACO.0000000000000715
  18. Vrecenak JD, Chuang AZ, Jea A. Hydrocephalus in pregnancy: a systematic review. World Neurosurg. 2017;107:677–84. doi: 10.1016/j.wneu.2017.07.170
  19. Leslie K, Absalom AR. The role of TCI propofol in neuroanaesthesia: evidence and clinical application. Anaesthesia. 2018;73(S1):66–74. doi: 10.1111/anae.14175
  20. Ryalino C, Putra A. Perioperative management in pregnant women undergoing non-obstetric surgery: a review of current practice. Anesth Pain Med. 2021;11(5):e118490. doi: 10.5812/aapm.118490

Last update:

No citation recorded.

Last update: 2025-11-29 16:06:53

No citation recorded.